Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Rossi

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|August 1, 1991
Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapyM Attal, F Huguet, D Schlaifer, et al.
Blood|July 27, 2001
Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arraysJ De Vos, G Couderc, K Tarte, et al.
Bone Marrow Transplantation|October 20, 2010
Ancestim (r-metHuSCF) plus filgrastim and/or chemotherapy for mobilization of blood progenitors in 513 poorly mobilizing cancer patients: the French compassionate experienceV Lapierre, J-F Rossi, F Heshmati, et al.
Current Topics in Microbiology and Immunology|July 9, 1999
Activation molecules on human myeloma cellsB Klein, X Y Li, Z Y Lu, et al.
Cancer|December 18, 2001
Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignanciesT Lavabre-Bertrand, L Henry, S Carillo, et al.
British Journal of Haematology|December 1, 1990
Micro-osteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myelomaJ F Rossi, D Chappard, C Marcelli, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1990
[Contribution of immunologic technics to the characterization of lethal midline granuloma of unknown origin]J Cabane, A Dubois, P Godeau, et al.
British Journal of Cancer|September 3, 2010
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancerJ-F Rossi, S Négrier, N D James, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Treatment of mantle-cell lymphomas with the VAD +/- chlorambucil regimen with or without subsequent high-dose therapy and peripheral blood stem-cell transplantationR Gressin, E Legouffe, D Leroux, et al.
British Journal of Cancer|October 1, 2009
Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I studyJ-F Rossi, J Moreaux, D Hose, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|August 1, 1991
Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapyM Attal, F Huguet, D Schlaifer, et al.
Blood|July 27, 2001
Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arraysJ De Vos, G Couderc, K Tarte, et al.
Bone Marrow Transplantation|October 20, 2010
Ancestim (r-metHuSCF) plus filgrastim and/or chemotherapy for mobilization of blood progenitors in 513 poorly mobilizing cancer patients: the French compassionate experienceV Lapierre, J-F Rossi, F Heshmati, et al.
Current Topics in Microbiology and Immunology|July 9, 1999
Activation molecules on human myeloma cellsB Klein, X Y Li, Z Y Lu, et al.
Cancer|December 18, 2001
Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignanciesT Lavabre-Bertrand, L Henry, S Carillo, et al.
British Journal of Haematology|December 1, 1990
Micro-osteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myelomaJ F Rossi, D Chappard, C Marcelli, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1990
[Contribution of immunologic technics to the characterization of lethal midline granuloma of unknown origin]J Cabane, A Dubois, P Godeau, et al.
British Journal of Cancer|September 3, 2010
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancerJ-F Rossi, S Négrier, N D James, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Treatment of mantle-cell lymphomas with the VAD +/- chlorambucil regimen with or without subsequent high-dose therapy and peripheral blood stem-cell transplantationR Gressin, E Legouffe, D Leroux, et al.
British Journal of Cancer|October 1, 2009
Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I studyJ-F Rossi, J Moreaux, D Hose, et al.
Pageof 12